Anzeige
Mehr »
Donnerstag, 03.07.2025 - Börsentäglich über 12.000 News
Nach dem Genius Act: Dieses börsennotierte XRP-Unternehmen greift im Token-Finanzmarkt an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
529 Leser
Artikel bewerten:
(2)

Virtusa Corporation: Virtusa Accelerates the Modernization and Personalization of Patient Care

vLife 6.0 Application Marketplace for Healthcare and Life Sciences

SOUTHBOROUGH, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Virtusa Corporation, a global provider of digital strategy, digital engineering, and IT services and solutions, today announced vLife 6.0, a cloud-based marketplace designed to improve and personalize patient care.

vLife 6.0 brings together previously inaccessible data with artificial intelligence (AI) applications, machine learning (ML) models, and industry-specific solutions - accessed via a self-service portal. vLife was developed in collaboration with leading universities and healthcare providers and has proven to accelerate the personalization of patient care.

The U.S. healthcare system alone generates approximately one trillion gigabytes of data annually. vLife 6.0 gives payers, providers, and medical device and life sciences companies the ability to capture, share and deliver data in a more unified way, which can increase productivity by approximately 30 percent.

Automating everything from data entry to medicine distribution and research analysis gives doctors and nurses the resources and the additional time needed to provide the best-personalized, quality care to each patient. By using AI tools and applications available in the vLife marketplace, healthcare providers can reduce diagnostic errors and provide the most up-to-date research and resources to support decision-making.

According to Business Insider Intelligence, 30 percent of healthcare costs are associated with administrative tasks. With the right solutions in place, organizations can automate administrative tasks, ease workflows, and analyze large data sets to deliver better healthcare faster, and at a lower cost. Among the key new features in vLife 6.0 is vNet, an enterprise AI application for building faster, smarter, and better ML models for harnessing all data.

By taking advantage of vLife 6.0, users can quickly start using pre-trained ML models, snippets of code, and accelerators to address specific healthcare-related tasks or functions.

"Healthcare and life sciences organizations need to access previously untapped patient data to drive operational efficiency, enhance the patient/provider experience, and ultimately provide more effective patient care," said Anthony Lange, Senior Vice President, Healthcare and Life Sciences, Virtusa. "With vLife 6.0, we're making it possible to quickly assemble and roll out pre-built models, applications and solutions designed by and with industry experts and digital engineers."

ML applications can potentially improve the accuracy of treatment protocols and health outcomes through algorithmic processes. For example, deep learning, a type of complex ML that mimics how the human brain functions, is increasingly being used in radiology and medical imaging. Using neural networks that can learn from data without any supervision, deep learning applications can detect, recognize and analyze cancerous lesions from images.

Today physicians spend too much time using EHR-According to a 2020 Annals of Internal Medicine study, Physicians spent an average of 16 minutes and 14 seconds per encounter using EHRs. vLife 6.0 has applications to identify documentation gaps and prepopulate problem lists, enabling physicians to spend more valuable time with patients and less time at the computer.

Built on Amazon Web Services (AWS), vLife 6.0 provides access to the following:

  • One billion rows of clinical, claims, genomic and IBM MarketScan research data as well as simulated data for the full U.S. population across 34 disease conditions.
  • One thousand AI artifacts for partners to build ML models based on their organizational priorities and project budget.
  • Industry solutions designed to address specific challenges, functions or tasks.

vLife includes specialized offerings for key segments, including:

  • Biopharma: Clinical trials, Commercial analytics, Patient engagement, Bioinformatics-as-a-Service (BaaS)
  • MedTech: Commercial solutions, Connected solutions, Patient engagement, Provider and patient engagement
  • Payer services: Member journey, Claims processing, Care management, Provider journey
  • Provider services: Population Health Management (PHM), Patient engagement, Ancillaries, Virtual care, Advanced analytics

Key features and benefits of vNet:

  • Faster AI: An intuitive AI tool that enables users with no AI coding skills to easily build, train, and deploy ML models, all in one place, without writing a single line of code. Faster AI empowers teams to operationalize AI and drive business value.
  • Computer Vision: No-code/low-code image analytics platform that allows beginners to get started quickly and AI experts to develop faster and leverage custom code with a fully managed infrastructure for computer vision.
  • Synthetic Data: Uses algorithms to create artificial data by mirroring the statistical properties of the original data while allowing business to maintain user privacy, successfully carry out product testing, and train ML algorithms
  • Innovation as a Service (IaaS): Connects every step of the domain journey and hosts several solutions to help customers efficiently improve the cognitive system of the domain systems across various AI-driven innovations.

With personalization at the center of a new age of healthcare, patients will be able to reach new levels of health and wellness, while allowing providers to operate more efficiently and effectively. vLife 6.0 paves the way for the future of healthcare and patient care.

To learn more about vLife, visit www.virtusa.com/vlife

About Virtusa

Virtusa Corporation is a global provider of digital business strategy, digital engineering, and information technology (IT) services and solutions that help clients change, disrupt, and unlock new value through innovation engineering. Virtusa serves Global 2000 companies in the Banking, Financial Services, Insurance, Healthcare, Communications, Media, Entertainment, Travel, Manufacturing, and Technology industries.

Virtusa helps clients grow their business with innovative products and services that create operational efficiency using digital labor, future-proof operational and IT platforms, and rationalization and modernization of IT applications infrastructure. This is achieved through a unique approach blending deep contextual expertise, empowered agile teams, and measurably better engineering to create holistic solutions that drive business forward at unparalleled velocity enabled by a culture of cooperative disruption.

Virtusa is registered trademark of Virtusa Corporation. All other company and brand names may be trademarks or service marks of their respective holders.

Contact:

Matt Berry
Conversion Marketing
(201) 370-9133
matt@conversionam.com


© 2021 GlobeNewswire (Europe)
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.